Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10060342HBVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS10060343HBVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30012008HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30006644HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30006645HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30012009HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30002359HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30012010HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30038887HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TVIS30038888HIVENSG00000140464.20protein_codingPMLNoYes5371P29590
TCGA Plot Options
Drug Information
GenePML
DrugBank IDDB01169
Drug NameArsenic trioxide
Target IDBE0005808
UniProt IDP29590
Regulation Type
PubMed IDs20378816
CitationsZhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de The H, Chen SJ, Chen Z: Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science. 2010 Apr 9;328(5975):240-3. doi: 10.1126/science.1183424.
GroupsApproved; Investigational
Direct ClassificationMetalloid oxides
SMILESO=[As]O[As]=O
Pathways
PharmGKBPA448486
ChEMBLCHEMBL1200978